Author

Theresia Mair

Medical University of ViennaORCID 0000-0003-0435-5258Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Gerda EggeriD· 3 shared Andreas TiefenbacheriD· 2 shared Anil Baskan· 2 shared Jessica KallaiD· 2 shared Kristina DraganićiD· 2 shared Aleksej DrinoiD· 1 shared Alexandra PodhornikiD· 1 shared Carlos Uziel Pérez MallaiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Gerda EggerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCell Reports MethodsPeer-reviewedMar 30, 2026

Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-loss

Jessica Kalla, Thomas Dillinger, Zlata Pavlovicova…·Gerda Egger

This study establishes a murine tumoroid biobank to identify oncogenic pathways and drug vulnerabilities in prostate cancer, finding that PTEN loss drives cancer pathways and that specific compounds inhibit tumor growth.

1 citation

mouseorganoid / primary culture

𝕏 PostBluesky

GeneticseLifePeer-reviewedMar 20, 2025

The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition

Gülnihal Kavaklıoğlu, Alexandra Podhornik, Terezia Vcelkova…·Christian Seiser

This study identifies L1TD1's role in promoting LINE-1 retrotransposition by interacting with L1 ORF1p, linking it to cancer progression and early development.

5 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologyMolecular OncologyPeer-reviewedMar 11, 2025

Aggressive KRAS mutations direct TGF-β response towards partial EMT in patient-derived colorectal cancer tumoroids

Theresia Mair, Philip König, Milena Mijović…·Gerda Egger

This study investigates how TGF-β affects colorectal cancer tumoroids, finding that aggressive KRAS mutations lead to partial EMT and increased invasiveness.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky